General Discussion 169 7 35. Marques BCAA, Klein MRST, da Cunha MR, et al. Effects of Oral Magnesium Supplementation on Vascular Function: A Systematic Review and Meta-analysis of Randomized Controlled Trials. High Blood Press Cardiovasc Prev. 2020;27(1):19-28. doi:10.1007/s40292-019-00355-z 36. Taniwaki H, Kawagishi T, Emoto M, et al. Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes: Vessel wall properties in type 2 diabetes. Diabetes Care. 1999. doi:10.2337/diacare.22.11.1851 37. Kimoto E, Shoji T, Shinohara K, et al. Preferential stiffening of central over peripheral arteries in type 2 diabetes. Diabetes. 2003. doi:10.2337/diabetes.52.2.448 38. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis. N Engl J Med. 2000. doi:10.1056/ nejm200005183422003 39. Lacolley P, Regnault V, Avolio AP. Smooth muscle cell and arterial aging: Basic and clinical aspects. Cardiovasc Res. 2018. doi:10.1093/cvr/cvy009 40. Hassan NA, D’Orsi ET, D’Orsi CJ, Charles O’Neill W. The risk for medial arterial calcification in CKD. Clin J Am Soc Nephrol. 2012. doi:10.2215/CJN.06490711 41. Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens. 2003. doi:10.1097/00004872-20030100000002 42. Shroff RC, McNair R, Skepper JN, et al. Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol. 2010. doi:10.1681/ASN.2009060640 43. Ter Braake AD, Shanahan CM, De Baaij JHF. Magnesium Counteracts Vascular Calcification: Passive Interference or Active Modulation? Arterioscler Thromb Vasc Biol. 2017. doi:10.1161/ ATVBAHA.117.309182 44. Diaz-Tocados JM, Peralta-Ramirez A, Rodríguez-Ortiz ME, et al. Dietary magnesium supplementation prevents and reverses vascular and soft tissue calcifications in uremic rats. Kidney Int. 2017. doi:10.1016/j.kint.2017.04.011 45. Hutchison AJ. Oral phosphate binders. Kidney Int. 2009. doi:10.1038/ki.2009.60 46. Ter Braake AD, Eelderink C, Zeper LW, et al. Calciprotein particle inhibition explains magnesium-mediated protection against vascular calcification. Nephrol Dial Transplant. 2020. doi:10.1093/ndt/gfz190 47. Kircelli F, Peter ME, Sevinc Ok E, et al. Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant. 2012. doi:10.1093/ ndt/gfr321 48. Pasch A, Farese S, Gräber S, et al. Nanoparticle-based test measures overall propensity for calcification in serum. J Am Soc Nephrol. 2012. doi:10.1681/ASN.2012030240 49. Sakaguchi Y, Hamano T, Obi Y, et al. A randomized trial of magnesium oxide and oral carbon adsorbent for coronary artery calcification in predialysis CKD. J Am Soc Nephrol. 2019. doi:10.1681/ASN.2018111150 50. Bressendorff I, Hansen D, Schou M, et al. Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity—A Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial. Kidney Int Reports. 2017. doi:10.1016/j.ekir.2016.12.008
RkJQdWJsaXNoZXIy MTk4NDMw